| 1 | registration | 2,569 |
| 2 | tai | 817 |
| 3 | copy | 623 |
| 4 | symbol | 282 |
| 5 | registration- | 97 |
| 6 | reynolds | 95 |
| 7 | accession | 90 |
| 8 | nusselt | 41 |
| 9 | t'ai | 40 |
| 10 | rayleigh | 25 |
| 11 | prandtl | 20 |
| 12 | free-drug | 18 |
| 13 | registration-url | 18 |
| 14 | tessier | 18 |
| 15 | fail-safe | 16 |
| 16 | biot | 14 |
| 17 | tn5 | 11 |
| 18 | equia | 10 |
| 19 | norditropin | 10 |
| 20 | sherwood | 8 |
| 21 | clarinet | 7 |
| 22 | geminal | 7 |
| 23 | peclet | 7 |
| 24 | practitioner-specific | 7 |
| 25 | tmpa | 7 |
| 26 | 3:4 | 5 |
| 27 | mts-c | 5 |
| 28 | p1060 | 5 |
| 29 | pathfinder | 5 |
| 30 | govt | 4 |
| 31 | graetz | 4 |
| 32 | left-breast | 4 |
| 33 | mrec | 4 |
| 34 | registeration | 4 |
| 35 | rossby | 4 |
| 36 | ty2 | 4 |
| 37 | urls | 4 |
| 38 | 9480 | 3 |
| 39 | c0405 | 3 |
| 40 | cys580tyr | 3 |
| 41 | d600 | 3 |
| 42 | mantra-paf | 3 |
| 43 | nasrbo3 | 3 |
| 44 | péclet | 3 |
| 45 | r-04 | 3 |
| 46 | remoxtb | 3 |
| 47 | spansule | 3 |
| 48 | stop-hf | 3 |
| 49 | vusa | 3 |
| 50 | x2-type | 3 |
| 51 | 25-o-desacetyl-rifabutin | 2 |
| 52 | 8956 | 2 |
| 53 | advance-on | 2 |
| 54 | after-infusion | 2 |
| 55 | appraise-2 | 2 |
| 56 | cacbt | 2 |
| 57 | cattaneo | 2 |
| 58 | complications- | 2 |
| 59 | damköhler | 2 |
| 60 | eckert | 2 |
| 61 | end-observation | 2 |
| 62 | eu-pact | 2 |
| 63 | koga | 2 |
| 64 | mcnamara | 2 |
| 65 | nct00737100 | 2 |
| 66 | nct00789373 | 2 |
| 67 | nct00893529 | 2 |
| 68 | nct01373879 | 2 |
| 69 | noncomplementary | 2 |
| 70 | pro-feiba | 2 |
| 71 | protect-pace | 2 |
| 72 | q-replete | 2 |
| 73 | rs16982743 | 2 |
| 74 | seraphin | 2 |
| 75 | topps | 2 |
| 76 | troica | 2 |
| 77 | tzu | 2 |
| 78 | v62t | 2 |
| 79 | 'gift' | 1 |
| 80 | 'minded | 1 |
| 81 | 'subject | 1 |
| 82 | 'tai | 1 |
| 83 | -2563 | 1 |
| 84 | -here | 1 |
| 85 | -spair | 1 |
| 86 | /glyburide | 1 |
| 87 | /incremental | 1 |
| 88 | /linagliptin | 1 |
| 89 | 0.006.the | 1 |
| 90 | 0.8857. | 1 |
| 91 | 1,1'-oxydimethylene | 1 |
| 92 | 1,3-dialkylimidazolium | 1 |
| 93 | 1-alkyl-3-vinylimidazolium | 1 |
| 94 | 1-butyl-3-methylpyrrolidinium | 1 |
| 95 | 12,982 | 1 |
| 96 | 13,661 | 1 |
| 97 | 15-89 | 1 |
| 98 | 1991. | 1 |
| 99 | 2012-001540-22 | 1 |
| 100 | 242,5-monthly | 1 |
| 101 | 3-iron | 1 |
| 102 | 3-methylimidazolium | 1 |
| 103 | 32-microg/ml | 1 |
| 104 | 4-16× | 1 |
| 105 | 4.3±6.6 | 1 |
| 106 | 58831 | 1 |
| 107 | 58832 | 1 |
| 108 | 8/german | 1 |
| 109 | =pseudochattonella | 1 |
| 110 | a1444040 | 1 |
| 111 | aah-nac | 1 |
| 112 | ab20/99 | 1 |
| 113 | acetamidomethylsulfonyl | 1 |
| 114 | actrn12611000067976 | 1 |
| 115 | adenomas/total | 1 |
| 116 | ally-2 | 1 |
| 117 | amplify-ext | 1 |
| 118 | amsl0 | 1 |
| 119 | analysis/synthesis | 1 |
| 120 | anrs-hc02 | 1 |
| 121 | apc.warning | 1 |
| 122 | ara-c/ | 1 |
| 123 | artery/total | 1 |
| 124 | atcc6919 | 1 |
| 125 | aver-age | 1 |
| 126 | bc2001 | 1 |
| 127 | benzannulated | 1 |
| 128 | bile-to-plasma | 1 |
| 129 | boat-shaped | 1 |
| 130 | brfad2 | 1 |
| 131 | c^n^c-coordinating | 1 |
| 132 | caisse | 1 |
| 133 | call-in | 1 |
| 134 | cap-start | 1 |
| 135 | carbon-nitrated | 1 |
| 136 | catheterization- | 1 |
| 137 | celiprev | 1 |
| 138 | certifi | 1 |
| 139 | cetane | 1 |
| 140 | cfum | 1 |
| 141 | chagasazol | 1 |
| 142 | characteristics.one | 1 |
| 143 | chest-2 | 1 |
| 144 | chictr-trc-11001504 | 1 |
| 145 | cluster-randomizes | 1 |
| 146 | cmx001-201 | 1 |
| 147 | cobrim | 1 |
| 148 | conservation/viral | 1 |
| 149 | contraception.results | 1 |
| 150 | copay/coinsurance | 1 |
| 151 | d'assurance | 1 |
| 152 | d-14 | 1 |
| 153 | darcy-rayleigh | 1 |
| 154 | debridement-antibiotictherapy | 1 |
| 155 | delivered/required | 1 |
| 156 | deviations/treatment | 1 |
| 157 | dose-had | 1 |
| 158 | dqtcf | 1 |
| 159 | dual-x-second-generation | 1 |
| 160 | effect.moderate | 1 |
| 161 | einstein-pe | 1 |
| 162 | eloquent-2 | 1 |
| 163 | evedience | 1 |
| 164 | fhdh-anrs | 1 |
| 165 | firm-act | 1 |
| 166 | florali | 1 |
| 167 | fm-modified | 1 |
| 168 | froude | 1 |
| 169 | gaetano | 1 |
| 170 | galilean | 1 |
| 171 | gauk | 1 |
| 172 | gd-doped | 1 |
| 173 | gdp-d-man | 1 |
| 174 | hkctr-1307 | 1 |
| 175 | hkctr-1343 | 1 |
| 176 | hmu | 1 |
| 177 | ht-equivalent | 1 |
| 178 | inceasing | 1 |
| 179 | intac | 1 |
| 180 | intolerance/inefficacy | 1 |
| 181 | iodixa | 1 |
| 182 | ion-2 | 1 |
| 183 | ion-3 | 1 |
| 184 | ion-extraction | 1 |
| 185 | irct138804212150n1 | 1 |
| 186 | isopropylidendithio | 1 |
| 187 | isrctn31379280 | 1 |
| 188 | isrctn62237498 | 1 |
| 189 | isrctn89493983eudract | 1 |
| 190 | jospt | 1 |
| 191 | keynote-006 | 1 |
| 192 | kodiac-05 | 1 |
| 193 | larege | 1 |
| 194 | latent-variable-based | 1 |
| 195 | ldl-p. | 1 |
| 196 | lesions.clinicaltrials.gov | 1 |
| 197 | lifenox | 1 |
| 198 | liferandomisation | 1 |
| 199 | linearly-increased | 1 |
| 200 | lipidohramy | 1 |
| 201 | lorazepan | 1 |
| 202 | lvp/n-butyl-n-methylpyrrolidinium | 1 |
| 203 | lym-3002 | 1 |
| 204 | m3-to-mk-7246 | 1 |
| 205 | mainritsan | 1 |
| 206 | mcmemar | 1 |
| 207 | mensa | 1 |
| 208 | milo | 1 |
| 209 | most-probable | 1 |
| 210 | mutation.results | 1 |
| 211 | n-weighed | 1 |
| 212 | n2+h2 | 1 |
| 213 | nanoparticl | 1 |
| 214 | nct00185211 | 1 |
| 215 | nct00276757 | 1 |
| 216 | nct00378508 | 1 |
| 217 | nct00409071 | 1 |
| 218 | nct00451425 | 1 |
| 219 | nct00515827 | 1 |
| 220 | nct00637195 | 1 |
| 221 | nct00922038 | 1 |
| 222 | nct00975026 | 1 |
| 223 | nct00991471 | 1 |
| 224 | nct01029067 | 1 |
| 225 | nct01065415 | 1 |
| 226 | nct01119846 | 1 |
| 227 | nct01949038 | 1 |
| 228 | ncto01605760 | 1 |
| 229 | nn8022-1839 | 1 |
| 230 | nnosμ-derived | 1 |
| 231 | nocturia-frequency-incomplete | 1 |
| 232 | noncombinability | 1 |
| 233 | nonheterocyclic | 1 |
| 234 | often-disappointing | 1 |
| 235 | opal-hk | 1 |
| 236 | osler-2 | 1 |
| 237 | ovariole | 1 |
| 238 | oxoanions | 1 |
| 239 | oxomolybdenum | 1 |
| 240 | pactr201008000221638 | 1 |
| 241 | paloma3 | 1 |
| 242 | parietal-frontal | 1 |
| 243 | partner-knowledge | 1 |
| 244 | patent-2 | 1 |
| 245 | patnrp1 | 1 |
| 246 | photo-protection | 1 |
| 247 | physiotherapy60 | 1 |
| 248 | plasma/peritoneal | 1 |
| 249 | poems/s0230 | 1 |
| 250 | potato-dextrose | 1 |
| 251 | prami | 1 |
| 252 | pregnancy.results | 1 |
| 253 | project/innovation | 1 |
| 254 | propane-1,1- | 1 |
| 255 | proseva | 1 |
| 256 | prosody-voice | 1 |
| 257 | protocol-with | 1 |
| 258 | quarisma | 1 |
| 259 | quasi-nil | 1 |
| 260 | raltegravir-glucuronide/raltegravir | 1 |
| 261 | re-sonate | 1 |
| 262 | reforpost | 1 |
| 263 | regestration | 1 |
| 264 | registation | 1 |
| 265 | registration-clinical | 1 |
| 266 | registrationl | 1 |
| 267 | regristration | 1 |
| 268 | relief.similar | 1 |
| 269 | risk-takers | 1 |
| 270 | rs16890282 | 1 |
| 271 | rt.eudract | 1 |
| 272 | salivarius-bacitracin | 1 |
| 273 | sapphire-i | 1 |
| 274 | sapphire-ii | 1 |
| 275 | sare | 1 |
| 276 | seism | 1 |
| 277 | sepsispam | 1 |
| 278 | sequence-affecting | 1 |
| 279 | seria | 1 |
| 280 | sgrq.the | 1 |
| 281 | sound-c2 | 1 |
| 282 | sourcing-the | 1 |
| 283 | stage/ | 1 |
| 284 | stop-it | 1 |
| 285 | strouhal | 1 |
| 286 | study/design | 1 |
| 287 | swog-9704 | 1 |
| 288 | tacrolimus.the | 1 |
| 289 | target-species | 1 |
| 290 | thapca-oh | 1 |
| 291 | these.secondary | 1 |
| 292 | tiantai | 1 |
| 293 | tmc207-c208 | 1 |
| 294 | trials.number | 1 |
| 295 | trialthe | 1 |
| 296 | tumorapa | 1 |
| 297 | turquoise-ii | 1 |
| 298 | udp‑gal | 1 |
| 299 | underclinicaltrials.gov | 1 |
| 300 | us.a | 1 |
| 301 | vulvovaginitis.methods | 1 |
| 302 | vx08-770-102 | 1 |
| 303 | williams-corrected | 1 |
| 304 | z-standardised | 1 |
| 305 | zoe-50 | 1 |
| 306 | zymoseptoria | 1 |
| 307 | ~fourfold | 1 |
| 308 | ¹³c-ring | 1 |
| 309 | ω-dithiaalkanediyl-bridged | 1 |
| 1 | 'gift' | 1 |
| 2 | 'minded | 1 |
| 3 | 'subject | 1 |
| 4 | 'tai | 1 |
| 5 | -2563 | 1 |
| 6 | -here | 1 |
| 7 | -spair | 1 |
| 8 | /glyburide | 1 |
| 9 | /incremental | 1 |
| 10 | /linagliptin | 1 |
| 11 | 0.006.the | 1 |
| 12 | 0.8857. | 1 |
| 13 | 1,1'-oxydimethylene | 1 |
| 14 | 1,3-dialkylimidazolium | 1 |
| 15 | 1-alkyl-3-vinylimidazolium | 1 |
| 16 | 1-butyl-3-methylpyrrolidinium | 1 |
| 17 | 12,982 | 1 |
| 18 | 13,661 | 1 |
| 19 | 15-89 | 1 |
| 20 | 1991. | 1 |
| 21 | 2012-001540-22 | 1 |
| 22 | 242,5-monthly | 1 |
| 23 | 25-o-desacetyl-rifabutin | 2 |
| 24 | 3-iron | 1 |
| 25 | 3-methylimidazolium | 1 |
| 26 | 32-microg/ml | 1 |
| 27 | 3:4 | 5 |
| 28 | 4-16× | 1 |
| 29 | 4.3±6.6 | 1 |
| 30 | 58831 | 1 |
| 31 | 58832 | 1 |
| 32 | 8/german | 1 |
| 33 | 8956 | 2 |
| 34 | 9480 | 3 |
| 35 | =pseudochattonella | 1 |
| 36 | a1444040 | 1 |
| 37 | aah-nac | 1 |
| 38 | ab20/99 | 1 |
| 39 | accession | 90 |
| 40 | acetamidomethylsulfonyl | 1 |
| 41 | actrn12611000067976 | 1 |
| 42 | adenomas/total | 1 |
| 43 | advance-on | 2 |
| 44 | after-infusion | 2 |
| 45 | ally-2 | 1 |
| 46 | amplify-ext | 1 |
| 47 | amsl0 | 1 |
| 48 | analysis/synthesis | 1 |
| 49 | anrs-hc02 | 1 |
| 50 | apc.warning | 1 |
| 51 | appraise-2 | 2 |
| 52 | ara-c/ | 1 |
| 53 | artery/total | 1 |
| 54 | atcc6919 | 1 |
| 55 | aver-age | 1 |
| 56 | bc2001 | 1 |
| 57 | benzannulated | 1 |
| 58 | bile-to-plasma | 1 |
| 59 | biot | 14 |
| 60 | boat-shaped | 1 |
| 61 | brfad2 | 1 |
| 62 | c0405 | 3 |
| 63 | c^n^c-coordinating | 1 |
| 64 | cacbt | 2 |
| 65 | caisse | 1 |
| 66 | call-in | 1 |
| 67 | cap-start | 1 |
| 68 | carbon-nitrated | 1 |
| 69 | catheterization- | 1 |
| 70 | cattaneo | 2 |
| 71 | celiprev | 1 |
| 72 | certifi | 1 |
| 73 | cetane | 1 |
| 74 | cfum | 1 |
| 75 | chagasazol | 1 |
| 76 | characteristics.one | 1 |
| 77 | chest-2 | 1 |
| 78 | chictr-trc-11001504 | 1 |
| 79 | clarinet | 7 |
| 80 | cluster-randomizes | 1 |
| 81 | cmx001-201 | 1 |
| 82 | cobrim | 1 |
| 83 | complications- | 2 |
| 84 | conservation/viral | 1 |
| 85 | contraception.results | 1 |
| 86 | copay/coinsurance | 1 |
| 87 | copy | 623 |
| 88 | cys580tyr | 3 |
| 89 | d'assurance | 1 |
| 90 | d-14 | 1 |
| 91 | d600 | 3 |
| 92 | damköhler | 2 |
| 93 | darcy-rayleigh | 1 |
| 94 | debridement-antibiotictherapy | 1 |
| 95 | delivered/required | 1 |
| 96 | deviations/treatment | 1 |
| 97 | dose-had | 1 |
| 98 | dqtcf | 1 |
| 99 | dual-x-second-generation | 1 |
| 100 | eckert | 2 |
| 101 | effect.moderate | 1 |
| 102 | einstein-pe | 1 |
| 103 | eloquent-2 | 1 |
| 104 | end-observation | 2 |
| 105 | equia | 10 |
| 106 | eu-pact | 2 |
| 107 | evedience | 1 |
| 108 | fail-safe | 16 |
| 109 | fhdh-anrs | 1 |
| 110 | firm-act | 1 |
| 111 | florali | 1 |
| 112 | fm-modified | 1 |
| 113 | free-drug | 18 |
| 114 | froude | 1 |
| 115 | gaetano | 1 |
| 116 | galilean | 1 |
| 117 | gauk | 1 |
| 118 | gd-doped | 1 |
| 119 | gdp-d-man | 1 |
| 120 | geminal | 7 |
| 121 | govt | 4 |
| 122 | graetz | 4 |
| 123 | hkctr-1307 | 1 |
| 124 | hkctr-1343 | 1 |
| 125 | hmu | 1 |
| 126 | ht-equivalent | 1 |
| 127 | inceasing | 1 |
| 128 | intac | 1 |
| 129 | intolerance/inefficacy | 1 |
| 130 | iodixa | 1 |
| 131 | ion-2 | 1 |
| 132 | ion-3 | 1 |
| 133 | ion-extraction | 1 |
| 134 | irct138804212150n1 | 1 |
| 135 | isopropylidendithio | 1 |
| 136 | isrctn31379280 | 1 |
| 137 | isrctn62237498 | 1 |
| 138 | isrctn89493983eudract | 1 |
| 139 | jospt | 1 |
| 140 | keynote-006 | 1 |
| 141 | kodiac-05 | 1 |
| 142 | koga | 2 |
| 143 | larege | 1 |
| 144 | latent-variable-based | 1 |
| 145 | ldl-p. | 1 |
| 146 | left-breast | 4 |
| 147 | lesions.clinicaltrials.gov | 1 |
| 148 | lifenox | 1 |
| 149 | liferandomisation | 1 |
| 150 | linearly-increased | 1 |
| 151 | lipidohramy | 1 |
| 152 | lorazepan | 1 |
| 153 | lvp/n-butyl-n-methylpyrrolidinium | 1 |
| 154 | lym-3002 | 1 |
| 155 | m3-to-mk-7246 | 1 |
| 156 | mainritsan | 1 |
| 157 | mantra-paf | 3 |
| 158 | mcmemar | 1 |
| 159 | mcnamara | 2 |
| 160 | mensa | 1 |
| 161 | milo | 1 |
| 162 | most-probable | 1 |
| 163 | mrec | 4 |
| 164 | mts-c | 5 |
| 165 | mutation.results | 1 |
| 166 | n-weighed | 1 |
| 167 | n2+h2 | 1 |
| 168 | nanoparticl | 1 |
| 169 | nasrbo3 | 3 |
| 170 | nct00185211 | 1 |
| 171 | nct00276757 | 1 |
| 172 | nct00378508 | 1 |
| 173 | nct00409071 | 1 |
| 174 | nct00451425 | 1 |
| 175 | nct00515827 | 1 |
| 176 | nct00637195 | 1 |
| 177 | nct00737100 | 2 |
| 178 | nct00789373 | 2 |
| 179 | nct00893529 | 2 |
| 180 | nct00922038 | 1 |
| 181 | nct00975026 | 1 |
| 182 | nct00991471 | 1 |
| 183 | nct01029067 | 1 |
| 184 | nct01065415 | 1 |
| 185 | nct01119846 | 1 |
| 186 | nct01373879 | 2 |
| 187 | nct01949038 | 1 |
| 188 | ncto01605760 | 1 |
| 189 | nn8022-1839 | 1 |
| 190 | nnosμ-derived | 1 |
| 191 | nocturia-frequency-incomplete | 1 |
| 192 | noncombinability | 1 |
| 193 | noncomplementary | 2 |
| 194 | nonheterocyclic | 1 |
| 195 | norditropin | 10 |
| 196 | nusselt | 41 |
| 197 | often-disappointing | 1 |
| 198 | opal-hk | 1 |
| 199 | osler-2 | 1 |
| 200 | ovariole | 1 |
| 201 | oxoanions | 1 |
| 202 | oxomolybdenum | 1 |
| 203 | p1060 | 5 |
| 204 | pactr201008000221638 | 1 |
| 205 | paloma3 | 1 |
| 206 | parietal-frontal | 1 |
| 207 | partner-knowledge | 1 |
| 208 | patent-2 | 1 |
| 209 | pathfinder | 5 |
| 210 | patnrp1 | 1 |
| 211 | peclet | 7 |
| 212 | photo-protection | 1 |
| 213 | physiotherapy60 | 1 |
| 214 | plasma/peritoneal | 1 |
| 215 | poems/s0230 | 1 |
| 216 | potato-dextrose | 1 |
| 217 | practitioner-specific | 7 |
| 218 | prami | 1 |
| 219 | prandtl | 20 |
| 220 | pregnancy.results | 1 |
| 221 | pro-feiba | 2 |
| 222 | project/innovation | 1 |
| 223 | propane-1,1- | 1 |
| 224 | proseva | 1 |
| 225 | prosody-voice | 1 |
| 226 | protect-pace | 2 |
| 227 | protocol-with | 1 |
| 228 | péclet | 3 |
| 229 | q-replete | 2 |
| 230 | quarisma | 1 |
| 231 | quasi-nil | 1 |
| 232 | r-04 | 3 |
| 233 | raltegravir-glucuronide/raltegravir | 1 |
| 234 | rayleigh | 25 |
| 235 | re-sonate | 1 |
| 236 | reforpost | 1 |
| 237 | regestration | 1 |
| 238 | registation | 1 |
| 239 | registeration | 4 |
| 240 | registration | 2,569 |
| 241 | registration- | 97 |
| 242 | registration-clinical | 1 |
| 243 | registration-url | 18 |
| 244 | registrationl | 1 |
| 245 | regristration | 1 |
| 246 | relief.similar | 1 |
| 247 | remoxtb | 3 |
| 248 | reynolds | 95 |
| 249 | risk-takers | 1 |
| 250 | rossby | 4 |
| 251 | rs16890282 | 1 |
| 252 | rs16982743 | 2 |
| 253 | rt.eudract | 1 |
| 254 | salivarius-bacitracin | 1 |
| 255 | sapphire-i | 1 |
| 256 | sapphire-ii | 1 |
| 257 | sare | 1 |
| 258 | seism | 1 |
| 259 | sepsispam | 1 |
| 260 | sequence-affecting | 1 |
| 261 | seraphin | 2 |
| 262 | seria | 1 |
| 263 | sgrq.the | 1 |
| 264 | sherwood | 8 |
| 265 | sound-c2 | 1 |
| 266 | sourcing-the | 1 |
| 267 | spansule | 3 |
| 268 | stage/ | 1 |
| 269 | stop-hf | 3 |
| 270 | stop-it | 1 |
| 271 | strouhal | 1 |
| 272 | study/design | 1 |
| 273 | swog-9704 | 1 |
| 274 | symbol | 282 |
| 275 | t'ai | 40 |
| 276 | tacrolimus.the | 1 |
| 277 | tai | 817 |
| 278 | target-species | 1 |
| 279 | tessier | 18 |
| 280 | thapca-oh | 1 |
| 281 | these.secondary | 1 |
| 282 | tiantai | 1 |
| 283 | tmc207-c208 | 1 |
| 284 | tmpa | 7 |
| 285 | tn5 | 11 |
| 286 | topps | 2 |
| 287 | trials.number | 1 |
| 288 | trialthe | 1 |
| 289 | troica | 2 |
| 290 | tumorapa | 1 |
| 291 | turquoise-ii | 1 |
| 292 | ty2 | 4 |
| 293 | tzu | 2 |
| 294 | udp‑gal | 1 |
| 295 | underclinicaltrials.gov | 1 |
| 296 | urls | 4 |
| 297 | us.a | 1 |
| 298 | v62t | 2 |
| 299 | vulvovaginitis.methods | 1 |
| 300 | vusa | 3 |
| 301 | vx08-770-102 | 1 |
| 302 | williams-corrected | 1 |
| 303 | x2-type | 3 |
| 304 | z-standardised | 1 |
| 305 | zoe-50 | 1 |
| 306 | zymoseptoria | 1 |
| 307 | ~fourfold | 1 |
| 308 | ¹³c-ring | 1 |
| 309 | ω-dithiaalkanediyl-bridged | 1 |
| 1 | 'gift' | 1 |
| 2 | propane-1,1- | 1 |
| 3 | registration- | 97 |
| 4 | catheterization- | 1 |
| 5 | complications- | 2 |
| 6 | 1991. | 1 |
| 7 | 0.8857. | 1 |
| 8 | ldl-p. | 1 |
| 9 | ara-c/ | 1 |
| 10 | stage/ | 1 |
| 11 | nct00737100 | 2 |
| 12 | d600 | 3 |
| 13 | poems/s0230 | 1 |
| 14 | a1444040 | 1 |
| 15 | zoe-50 | 1 |
| 16 | p1060 | 5 |
| 17 | ncto01605760 | 1 |
| 18 | physiotherapy60 | 1 |
| 19 | isrctn31379280 | 1 |
| 20 | 9480 | 3 |
| 21 | amsl0 | 1 |
| 22 | bc2001 | 1 |
| 23 | cmx001-201 | 1 |
| 24 | nct00185211 | 1 |
| 25 | 58831 | 1 |
| 26 | 13,661 | 1 |
| 27 | nct00409071 | 1 |
| 28 | nct00991471 | 1 |
| 29 | irct138804212150n1 | 1 |
| 30 | patnrp1 | 1 |
| 31 | appraise-2 | 2 |
| 32 | ion-2 | 1 |
| 33 | osler-2 | 1 |
| 34 | patent-2 | 1 |
| 35 | eloquent-2 | 1 |
| 36 | chest-2 | 1 |
| 37 | ally-2 | 1 |
| 38 | lym-3002 | 1 |
| 39 | vx08-770-102 | 1 |
| 40 | anrs-hc02 | 1 |
| 41 | 2012-001540-22 | 1 |
| 42 | 58832 | 1 |
| 43 | rs16890282 | 1 |
| 44 | 12,982 | 1 |
| 45 | sound-c2 | 1 |
| 46 | brfad2 | 1 |
| 47 | n2+h2 | 1 |
| 48 | ty2 | 4 |
| 49 | ion-3 | 1 |
| 50 | hkctr-1343 | 1 |
| 51 | rs16982743 | 2 |
| 52 | -2563 | 1 |
| 53 | nct00789373 | 2 |
| 54 | paloma3 | 1 |
| 55 | nasrbo3 | 3 |
| 56 | r-04 | 3 |
| 57 | chictr-trc-11001504 | 1 |
| 58 | swog-9704 | 1 |
| 59 | d-14 | 1 |
| 60 | 3:4 | 5 |
| 61 | kodiac-05 | 1 |
| 62 | c0405 | 3 |
| 63 | nct01065415 | 1 |
| 64 | nct00451425 | 1 |
| 65 | nct00637195 | 1 |
| 66 | tn5 | 11 |
| 67 | 4.3±6.6 | 1 |
| 68 | keynote-006 | 1 |
| 69 | nct00975026 | 1 |
| 70 | m3-to-mk-7246 | 1 |
| 71 | nct01119846 | 1 |
| 72 | 8956 | 2 |
| 73 | actrn12611000067976 | 1 |
| 74 | hkctr-1307 | 1 |
| 75 | nct00515827 | 1 |
| 76 | nct00276757 | 1 |
| 77 | nct01029067 | 1 |
| 78 | tmc207-c208 | 1 |
| 79 | nct00378508 | 1 |
| 80 | nct00922038 | 1 |
| 81 | nct01949038 | 1 |
| 82 | pactr201008000221638 | 1 |
| 83 | isrctn62237498 | 1 |
| 84 | atcc6919 | 1 |
| 85 | nct00893529 | 2 |
| 86 | nn8022-1839 | 1 |
| 87 | nct01373879 | 2 |
| 88 | 15-89 | 1 |
| 89 | ab20/99 | 1 |
| 90 | us.a | 1 |
| 91 | pro-feiba | 2 |
| 92 | troica | 2 |
| 93 | koga | 2 |
| 94 | seria | 1 |
| 95 | zymoseptoria | 1 |
| 96 | equia | 10 |
| 97 | =pseudochattonella | 1 |
| 98 | bile-to-plasma | 1 |
| 99 | quarisma | 1 |
| 100 | tumorapa | 1 |
| 101 | tmpa | 7 |
| 102 | mcnamara | 2 |
| 103 | mensa | 1 |
| 104 | vusa | 3 |
| 105 | proseva | 1 |
| 106 | iodixa | 1 |
| 107 | remoxtb | 3 |
| 108 | mts-c | 5 |
| 109 | aah-nac | 1 |
| 110 | intac | 1 |
| 111 | mrec | 4 |
| 112 | practitioner-specific | 7 |
| 113 | nonheterocyclic | 1 |
| 114 | dose-had | 1 |
| 115 | 'minded | 1 |
| 116 | ω-dithiaalkanediyl-bridged | 1 |
| 117 | n-weighed | 1 |
| 118 | fm-modified | 1 |
| 119 | boat-shaped | 1 |
| 120 | gd-doped | 1 |
| 121 | delivered/required | 1 |
| 122 | latent-variable-based | 1 |
| 123 | linearly-increased | 1 |
| 124 | z-standardised | 1 |
| 125 | benzannulated | 1 |
| 126 | carbon-nitrated | 1 |
| 127 | williams-corrected | 1 |
| 128 | nnosμ-derived | 1 |
| 129 | ~fourfold | 1 |
| 130 | sherwood | 8 |
| 131 | protect-pace | 2 |
| 132 | prosody-voice | 1 |
| 133 | copay/coinsurance | 1 |
| 134 | d'assurance | 1 |
| 135 | evedience | 1 |
| 136 | /glyburide | 1 |
| 137 | froude | 1 |
| 138 | fail-safe | 16 |
| 139 | aver-age | 1 |
| 140 | partner-knowledge | 1 |
| 141 | larege | 1 |
| 142 | sourcing-the | 1 |
| 143 | 0.006.the | 1 |
| 144 | sgrq.the | 1 |
| 145 | tacrolimus.the | 1 |
| 146 | trialthe | 1 |
| 147 | most-probable | 1 |
| 148 | ovariole | 1 |
| 149 | spansule | 3 |
| 150 | cetane | 1 |
| 151 | 1,1'-oxydimethylene | 1 |
| 152 | characteristics.one | 1 |
| 153 | einstein-pe | 1 |
| 154 | x2-type | 3 |
| 155 | sare | 1 |
| 156 | -here | 1 |
| 157 | potato-dextrose | 1 |
| 158 | caisse | 1 |
| 159 | re-sonate | 1 |
| 160 | effect.moderate | 1 |
| 161 | q-replete | 2 |
| 162 | nocturia-frequency-incomplete | 1 |
| 163 | mantra-paf | 3 |
| 164 | dqtcf | 1 |
| 165 | stop-hf | 3 |
| 166 | apc.warning | 1 |
| 167 | ¹³c-ring | 1 |
| 168 | inceasing | 1 |
| 169 | c^n^c-coordinating | 1 |
| 170 | sequence-affecting | 1 |
| 171 | often-disappointing | 1 |
| 172 | free-drug | 18 |
| 173 | rayleigh | 25 |
| 174 | darcy-rayleigh | 1 |
| 175 | thapca-oh | 1 |
| 176 | protocol-with | 1 |
| 177 | sapphire-i | 1 |
| 178 | t'ai | 40 |
| 179 | tai | 817 |
| 180 | 'tai | 1 |
| 181 | tiantai | 1 |
| 182 | certifi | 1 |
| 183 | sapphire-ii | 1 |
| 184 | turquoise-ii | 1 |
| 185 | florali | 1 |
| 186 | prami | 1 |
| 187 | opal-hk | 1 |
| 188 | gauk | 1 |
| 189 | registration-clinical | 1 |
| 190 | plasma/peritoneal | 1 |
| 191 | udp‑gal | 1 |
| 192 | strouhal | 1 |
| 193 | geminal | 7 |
| 194 | conservation/viral | 1 |
| 195 | /incremental | 1 |
| 196 | parietal-frontal | 1 |
| 197 | adenomas/total | 1 |
| 198 | artery/total | 1 |
| 199 | nanoparticl | 1 |
| 200 | quasi-nil | 1 |
| 201 | 32-microg/ml | 1 |
| 202 | registrationl | 1 |
| 203 | symbol | 282 |
| 204 | chagasazol | 1 |
| 205 | registration-url | 18 |
| 206 | prandtl | 20 |
| 207 | acetamidomethylsulfonyl | 1 |
| 208 | sepsispam | 1 |
| 209 | cobrim | 1 |
| 210 | seism | 1 |
| 211 | cfum | 1 |
| 212 | 3-methylimidazolium | 1 |
| 213 | 1,3-dialkylimidazolium | 1 |
| 214 | 1-alkyl-3-vinylimidazolium | 1 |
| 215 | 1-butyl-3-methylpyrrolidinium | 1 |
| 216 | lvp/n-butyl-n-methylpyrrolidinium | 1 |
| 217 | oxomolybdenum | 1 |
| 218 | galilean | 1 |
| 219 | gdp-d-man | 1 |
| 220 | 8/german | 1 |
| 221 | lorazepan | 1 |
| 222 | mainritsan | 1 |
| 223 | study/design | 1 |
| 224 | call-in | 1 |
| 225 | salivarius-bacitracin | 1 |
| 226 | seraphin | 2 |
| 227 | norditropin | 10 |
| 228 | /linagliptin | 1 |
| 229 | 25-o-desacetyl-rifabutin | 2 |
| 230 | advance-on | 2 |
| 231 | accession | 90 |
| 232 | after-infusion | 2 |
| 233 | dual-x-second-generation | 1 |
| 234 | registeration | 4 |
| 235 | regestration | 1 |
| 236 | registration | 2,569 |
| 237 | regristration | 1 |
| 238 | liferandomisation | 1 |
| 239 | registation | 1 |
| 240 | project/innovation | 1 |
| 241 | end-observation | 2 |
| 242 | ion-extraction | 1 |
| 243 | photo-protection | 1 |
| 244 | 3-iron | 1 |
| 245 | cattaneo | 2 |
| 246 | isopropylidendithio | 1 |
| 247 | milo | 1 |
| 248 | gaetano | 1 |
| 249 | relief.similar | 1 |
| 250 | mcmemar | 1 |
| 251 | trials.number | 1 |
| 252 | pathfinder | 5 |
| 253 | tessier | 18 |
| 254 | damköhler | 2 |
| 255 | -spair | 1 |
| 256 | raltegravir-glucuronide/raltegravir | 1 |
| 257 | cys580tyr | 3 |
| 258 | reynolds | 95 |
| 259 | vulvovaginitis.methods | 1 |
| 260 | target-species | 1 |
| 261 | cluster-randomizes | 1 |
| 262 | analysis/synthesis | 1 |
| 263 | urls | 4 |
| 264 | oxoanions | 1 |
| 265 | topps | 2 |
| 266 | risk-takers | 1 |
| 267 | fhdh-anrs | 1 |
| 268 | mutation.results | 1 |
| 269 | contraception.results | 1 |
| 270 | pregnancy.results | 1 |
| 271 | v62t | 2 |
| 272 | cacbt | 2 |
| 273 | firm-act | 1 |
| 274 | eu-pact | 2 |
| 275 | rt.eudract | 1 |
| 276 | isrctn89493983eudract | 1 |
| 277 | 'subject | 1 |
| 278 | peclet | 7 |
| 279 | péclet | 3 |
| 280 | clarinet | 7 |
| 281 | stop-it | 1 |
| 282 | nusselt | 41 |
| 283 | ht-equivalent | 1 |
| 284 | deviations/treatment | 1 |
| 285 | biot | 14 |
| 286 | jospt | 1 |
| 287 | cap-start | 1 |
| 288 | eckert | 2 |
| 289 | left-breast | 4 |
| 290 | reforpost | 1 |
| 291 | govt | 4 |
| 292 | amplify-ext | 1 |
| 293 | hmu | 1 |
| 294 | tzu | 2 |
| 295 | celiprev | 1 |
| 296 | lesions.clinicaltrials.gov | 1 |
| 297 | underclinicaltrials.gov | 1 |
| 298 | lifenox | 1 |
| 299 | rossby | 4 |
| 300 | intolerance/inefficacy | 1 |
| 301 | 242,5-monthly | 1 |
| 302 | lipidohramy | 1 |
| 303 | debridement-antibiotictherapy | 1 |
| 304 | copy | 623 |
| 305 | these.secondary | 1 |
| 306 | noncomplementary | 2 |
| 307 | noncombinability | 1 |
| 308 | graetz | 4 |
| 309 | 4-16× | 1 |